High-risk Renal Cell Carcinoma
1 clinical trials · Condition
◉ Watch High-risk Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer (NCT06584435) | Tianjin Medical University Second Hospital | 2022-10-10 |
Track High-risk Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.